FDA Approves New Treatment for Common Breast Cancer Type

Thousands of women with advanced breast cancer now have a powerful new option after hormone therapy stops working.

The FDA just approved REVTORPYK for the most common type of breast cancer, offering hope to patients who previously had limited choices.